GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Turmeric Acquisition Corp (NAS:TMPMU) » Definitions » Total Stockholders Equity

Turmeric Acquisition (Turmeric Acquisition) Total Stockholders Equity : $93.53 Mil (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Turmeric Acquisition Total Stockholders Equity?

Turmeric Acquisition's Total Stockholders Equity for the quarter that ended in Jun. 2022 was $93.53 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Turmeric Acquisition's Book Value per Share for the quarter that ended in Jun. 2022 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Turmeric Acquisition's Debt-to-Equity for the quarter that ended in Jun. 2022 was 0.00.

Turmeric Acquisition Total Stockholders Equity Historical Data

The historical data trend for Turmeric Acquisition's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turmeric Acquisition Total Stockholders Equity Chart

Turmeric Acquisition Annual Data
Trend Dec20 Dec21
Total Stockholders Equity
89.35 92.00

Turmeric Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Total Stockholders Equity Get a 7-Day Free Trial 92.04 92.33 92.00 92.78 93.53

Turmeric Acquisition  (NAS:TMPMU) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Turmeric Acquisition's Book Value per Share for the quarter that ended in Jun. 2022 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(93.531-0)/0
=N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Turmeric Acquisition's Debt-to-Equity for the quarter that ended in Jun. 2022 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 93.531
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Turmeric Acquisition Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Turmeric Acquisition's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Turmeric Acquisition (Turmeric Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Turmeric Acquisition Corp (NAS:TMPMU) » Definitions » Total Stockholders Equity
Comparable Companies
AVHI SGHL IGTA FRLA OTEC BWAQ OTRA VSAC ENCP LMAO GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
450 Kendall Street, Cambridge, MA, USA, 02142
Website
https://www.mpmcapital.com
Turmeric Acquisition Corp is a blank check company.
Executives
Luke Evnin officer: Chief Executive Officer THE JOHN HANCOCK TOWER, 200 CLARENDON STREET, 54TH STREET, BOSTON MA 02116
Mitchell H. Finer director C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Edward Hurwitz officer: Chief Financial Officer
Todd Foley officer: President THE JOHN HANCOCK TOWER, 200 CLARENDON STREET 54TH FLOOR, BOSTON MA 02116
Pablo J Cagnoni director ONYX PHARMACEUTICALS, INC., 249 E. GRAND AVE., SOUTH SAN FRANCISCO CA 94080
David P Meeker director C/O PENWEST PHARMACEUTICALS CO, 39 OLD RIDGEBURY ROAD SUITE 11, DANBURY CT 06810
Andrew R Robbins director C/O 3200 WALNUT ST, BOULDER CO 80301
Matthew Roden director 450 KENDALL STREET, CAMBRIDGE MA 02142
Turmeric Management, Llc 10 percent owner 450 KENDALL STREET, CAMBRIDGE MA 02142
Vinay Bhaskar officer: Chief Operating Officer 2000 SIERRA POINT PARKWAY, SUITE 701, BRISBANE CA 94005